Skip to content
Contact

Advanced Antibody Design Services

Macromoltek harnesses the power of computational modeling and artificial intelligence to accelerate and optimize the antibody discovery and engineering process. Our platform empowers biotech and pharmaceutical partners to design highly specific, effective antibodies, reducing time-to-market and increasing the probability of clinical success.

Explore Our SolutionsPartner With Us
rotatingMolecule

Our Antibody Design Services

AI-Driven Antibody Discovery

Leverage cutting-edge artificial intelligence to identify and optimize antibodies with high specificity and affinity. Our proprietary algorithms streamline the discovery process, enabling rapid identification of promising therapeutic candidates.

Computational Structure Modeling

Utilize advanced computational modeling tools to predict and refine antibody structures. Our technology enhances accuracy in epitope mapping, developability assessments, and structural optimization, reducing experimental cycles.

Custom Antibody Engineering Partnerships

Collaborate directly with our expert team to design and engineer antibodies tailored to your unique targets. We offer flexible partnership models for biotech and pharma companies, supporting projects from early research to clinical development.
Close up image of human hand holding test tube. Science concept

About Macromoltek

Macromoltek is a pioneering biotech company specializing in the use of advanced computational modeling and artificial intelligence to design next-generation antibodies. Serving both biotech and pharmaceutical partners, Macromoltek accelerates the discovery and optimization of therapeutic antibodies, transforming traditional drug development processes. Our innovative solutions help partners achieve breakthroughs in precision medicine, leading to more effective and targeted treatments.

Our Solutions: Next-Generation Antibody Design

At Macromoltek, we harness the power of advanced computational modeling and artificial intelligence to accelerate and revolutionize antibody discovery and engineering. Our proprietary technology enables biotech and pharmaceutical partners to streamline the development of highly specific, effective, and novel antibody therapeutics. From early-stage target identification to lead optimization, our integrated AI-driven platform delivers faster, more accurate candidate selection, reducing time and risk in the drug development pipeline. Partner with us to unlock innovative solutions tailored to your unique research and development needs.

Women_In_Bio_2 (2)

Monica Berrondo, PhD

CEO

Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems. Dr. Berrondo has authored over 10 peer-reviewed scientific articles in journals such as Proteins, JMB, and PLoS One.
Since moving to Austin, TX, she has already made her mark, being voted Austin Magazine’s Woman of the Year in 2013, winning Austin Startup Week’s Founder of the Year in 2015, pitching as a semi-finalist in the Circular Board pitch competition in Houston (April 2016), and being featured in a recent article in Inc. magazine (2016).

Women_In_Bio_5_crop

Susana Kaufmann

CTO

Susana Kaufmann is a software and algorithmic expert, with over 25 years of experience as a senior developer. She has cross-industry experience in inter-platform software development and computer simulation in the petrochemical, combustion, pharmaceutical and financial sectors. Susana has many years of successful delivery in technology services, having managed a software consulting company.
As Macromoltek’s CTO and co-founder, Susana has leveraged her deep knowledge of fluid dynamics in building the company’s advanced computational engine. Additionally, she has driven the development of Macromoltek’s database used for custom antibody design projects.

Contact Macromoltek

Interested in advancing your antibody discovery and development? Get in touch with Macromoltek’s experts to learn how our AI-driven computational modeling can accelerate your therapeutic pipeline and deliver innovative solutions for your biotech or pharma organization.